SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001493152-22-007380
Filing Date
2022-03-21
Accepted
2022-03-21 17:26:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 posam.htm POS AM 344707
2 ex23-1.htm EX-23.1 5012
3 ex24-2.htm EX-24.2 5226
4 ex107.htm EX-FILING FEES 17378
  Complete submission text file 0001493152-22-007380.txt   373405
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-230016 | Film No.: 22756501
SIC: 2834 Pharmaceutical Preparations